ライフサイエンスコーパス: adjusted for

1 Log-linear regressions were adjusted for a priori selected covariates to determine differ

2 sease Incidence and Carrier Estimation Algorithm) software, adjusted for age at baseline data collection.

3 When adjusted for age, height, race-sex group, peak lung function,

4 mortality was assessed with Cox proportional hazards models adjusted for age, sex, AMD severity, VA, history of cataract

5 ntia (adjusted hazard ratio [aHR], 1.28; 95% CI, 1.13-1.46) adjusted for age, sex, and race.

6 h 20/40 or better (HR, 1.56; 95% CI, 1.06-2.30; P = 0.024), adjusted for age, sex, and statistically significant covariat

7 incident parkinsonism per SD decrease in global cognition, adjusted for age, sex, and study subcohort.

8 d with the use of Cox proportional hazards models that were adjusted for age, sex, body mass index, smoking status, educa

9 P values were adjusted for age, sex, carotid artery site, and family relati

10 In models adjusted for age, sex, chronic disease, socioeconomic status

11 Calculations were based on proportional hazards models adjusted for age, sex, race, HIV risk group, calendar year, c

12 c melanomas were evaluated using logistic regression models adjusted for age, sex, study center, and primary status (sing

13 binding in multiple brain regions were compared by ANCOVA, adjusted for age.

14 ndard errors to accommodate for serial autocorrelation, and adjusted for any potential effect of birth seasonality on our

15 Pigs were randomly assigned to "control" (FIO2 0.3, adjusted for arterial oxygen saturation >/= 90%) and "hyperox

16 St-Cp We monitored patients with standardized protocols and adjusted for baseline characteristics by Cox regression.

17 We conducted conditional logistic regression analyses adjusted for body mass index, smoking, hypertension, diabetes

18 When adjusted for bronchopulmonary dysplasia, the difference in fl

19 Models were adjusted for calendar time and other potential confounding fa

20 to estimate cause-specific hazard ratios (HRs) for 12 CVDs, adjusted for cardiovascular risk factors and acute conditions

21 adjusted odds ratio [aOR] 0.83, 95% CI 0.70-0.99; I(2)=51%, adjusted for CD4 cell count and ART duration), and there was

22 fects models according to intention-to-treat principles and adjusted for centre and baseline weight.

23 on models were used to estimate odds ratios (ORs) that were adjusted for comorbidity, education level, and income level.

24 nd adjusted rate differences with 95% confidence intervals, adjusted for confounders (eg, maternal age and parity).

25 This finding is consistent when adjusted for confounders, like disease severity.

26 hazard ratios and 95% confidence intervals using Cox models adjusted for confounders.

27 nce intervals (CIs) using unconditional logistic regression adjusted for confounders.

28 However, when adjusted for confounding factors, African American subjects w

29 in OA patients (beta -0.41; 95% CI-0.69, -0.12; p < 0.005; adjusted for covariates) but not with radiographic osteoarthr

30 In multivariate models adjusted for demographics and vascular risk factors, higher l

31 4-1.40] and 1.81 [95% confidence interval 1.24-2.64], fully adjusted for each other, and conventional cardiovascular risk

32 ith a prior history of any MACE before MI were censored and adjusted for follow-up times.

33 The statistical analysis was adjusted for hospital and for risk factors.

34 unrelated to behavior, self-esteem and depressive symptoms adjusted for infant characteristics (sex, gestational age, bi

35 Costs were adjusted for inflation and reported in 2015 dollars.

36 Prices were adjusted for inflation.

37 We adjusted for multiple confounders including demographics, com

38 Multiple linear regression models adjusted for potential confounders were used to estimate asso

39 Analyses were adjusted for potential confounders.

40 osure were estimated using Cox proportional hazards models, adjusted for potential confounders.

41 When the FCAT test scores were adjusted for potentially confounding maternal and infant vari

42 ograft failure were assessed by multivariate Cox regression adjusted for recipient, donor, and transplant factors.

43 ntravenous infusion every 8 h) for 7-14 days; regimens were adjusted for renal function.

44 xecutive functioning test scores using linear mixed models, adjusted for sex and education, and meta-analytic techniques.

45 ith Cox proportional hazards and flexible parametric models adjusted for stratification factors.

46 Results were confirmed in regression analysis adjusted for team composition.

47 nal hazards model in which the impact of each covariate was adjusted for that of all others.

48 Time to readmission or death within 12 months adjusted for the number of previous COPD admissions, previous

49 associations using polynomial terms in spatial error models adjusted for total population and population density.

50 analyses and multivariate Cox proportional hazard modeling, adjusted for treatment, patient age, year of diagnosis, tumor